Sibel Ozler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sibel Ozler has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
Efser Oztas
Perinatology, Kütahya University of Health Sciences
10 shared publications- Dilek Sahin
Perinatology Department Ankara Bilkent City Hospital Ankara Turkey
8 shared publications Merve Ergin
Department of Pathology, Etlik Zübeyde Haním Women's Health Education and Research Hospital , Ankara , Turkey
8 shared publicationsBasak Gumus Guler
Department of Health Sciences, Istinye University , Istanbul , Turkey
6 shared publicationsNuri Danisman
Department of Perinatology, Acıbadem Acıbadem University Medical School , Istanbul , Turkey
6 shared publications- Ali Ozgur Ersoy
A Department of Perinatology , Zekai Tahir Burak Women's Health Care, Training and Research Hospital , Ankara , Turkey and
5 shared publications
Latest Publications
- Open Access
- 19 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Effect of vitamin D deficiency on pregnancy outcomes in obese and non-obese pregnant women
Obesity and vitamin D deficiency are significant risk factors for adverse pregnancy outcomes. While lower vitamin D levels are common in obese individuals,
- 19 May 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessEffect of vitamin D deficiency on pregnancy outcomes in obese and non-obese pregnant women
Obesity and vitamin D deficiency are significant risk factors for adverse pregnancy outcomes. While lower vitamin D levels are common in obese individuals,
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (6) , e20231574
The role of the Chitinase 3-Like 1 (CHI3L1) genes in the preeclampsia pathophysiology
The aim of this study was to investigate the relationship between Chitinase 3-Like 1 gene polymorphisms and the occurrence of preeclampsia in a selected cohort of pregnant women.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (6) , e20231574
Open AccessThe role of the Chitinase 3-Like 1 (CHI3L1) genes in the preeclampsia pathophysiology
The aim of this study was to investigate the relationship between Chitinase 3-Like 1 gene polymorphisms and the occurrence of preeclampsia in a selected cohort of pregnant women.
- 17 October 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 31 (3) , 803-810
Are Vascular Endothelium and Angiogenesis Effective MicroRNA Biomarkers Associated with the Prediction of Early-Onset Preeclampsia (EOPE) and Adverse Perinatal Outcomes?
MicroRNA is associated with angiogenesis, invasion, proliferation, and vascular endothelial remodeling of various diseases. We aimed to investigate serum MicroRNA (miRNA) levels in preeclampsia (PE) and to determine whether any changes in miRNA levels are useful in predicting early onset preeclampsia (EOPE) and adverse perinatal outcomes. A total of 89 pregnant patients were enrolled in this prospective case–control study (55 PE and 34 healthy controls). miR-17, miR-20a, miR-20b, miR126, miR155, miR-200, miR-222, and miR-210 levels were studied in maternal serum in preeclamptic pregnant women. Multiple logistic regression analyses analyzed the risk factors which are associated with EOPE and adverse maternal outcomes. The Real-time RT-PCR method was used to determine maternal serum miRNA levels. Serum miR-17, miR-20a, miR-20b, miR126, and miR-210 levels were significantly higher in PE than the control group (p < .001, p < .001, p < .001, p < .001 and p = .047 respectively). Increased miR-17, miR-20a, and miR-20b levels were independently associated with PE (OR: 0.642, 95%Cl: 0.486–0.846, p = .002; OR: 0.899, 95%Cl: 0.811–0.996, p = .042 and OR: 0.817, 95%Cl: 0.689–0.970, p = .021). Increased miR-17 and miR-126 levels were negatively correlated with serum EOPE in PE (r = -.313, p = .020), and increased miR-210 levels were significantly positively correlated with EOPE in PE (r = .285, p = .005). Increased expression of serum miR-17, miR-20a, miR-20b, miR126, and miR-210 were found to be associated with PE, also increased expression of miR-17, miR-20a, and miR-20b were to be predicted with PE, also increased maternal serum miR-17 and miR-126 expressions were negatively correlated and increased miR-210 expression was positively correlated with EOPE in PE women.
- 17 October 2023
- Published by Springer Nature in Reproductive Sciences
- Vol. 31 (3) , 803-810
Are Vascular Endothelium and Angiogenesis Effective MicroRNA Biomarkers Associated with the Prediction of Early-Onset Preeclampsia (EOPE) and Adverse Perinatal Outcomes?
MicroRNA is associated with angiogenesis, invasion, proliferation, and vascular endothelial remodeling of various diseases. We aimed to investigate serum MicroRNA (miRNA) levels in preeclampsia (PE) and to determine whether any changes in miRNA levels are useful in predicting early onset preeclampsia (EOPE) and adverse perinatal outcomes. A total of 89 pregnant patients were enrolled in this prospective case–control study (55 PE and 34 healthy controls). miR-17, miR-20a, miR-20b, miR126, miR155, miR-200, miR-222, and miR-210 levels were studied in maternal serum in preeclamptic pregnant women. Multiple logistic regression analyses analyzed the risk factors which are associated with EOPE and adverse maternal outcomes. The Real-time RT-PCR method was used to determine maternal serum miRNA levels. Serum miR-17, miR-20a, miR-20b, miR126, and miR-210 levels were significantly higher in PE than the control group (p < .001, p < .001, p < .001, p < .001 and p = .047 respectively). Increased miR-17, miR-20a, and miR-20b levels were independently associated with PE (OR: 0.642, 95%Cl: 0.486–0.846, p = .002; OR: 0.899, 95%Cl: 0.811–0.996, p = .042 and OR: 0.817, 95%Cl: 0.689–0.970, p = .021). Increased miR-17 and miR-126 levels were negatively correlated with serum EOPE in PE (r = -.313, p = .020), and increased miR-210 levels were significantly positively correlated with EOPE in PE (r = .285, p = .005). Increased expression of serum miR-17, miR-20a, miR-20b, miR126, and miR-210 were found to be associated with PE, also increased expression of miR-17, miR-20a, and miR-20b were to be predicted with PE, also increased maternal serum miR-17 and miR-126 expressions were negatively correlated and increased miR-210 expression was positively correlated with EOPE in PE women.
- Open Access
- 27 April 2023
- Published by Springer Nature in Research Square
Are vascular endothelium and angiogenesis effective MicroRNA Biomarkers associated with the prediction of early-onset preeclampsia (EOPE) and adverse perinatal outcomes?
Purpose : We aimed to investigate serum MicroRNA (miRNA) levels in preeclampsia (PE) and to determine whether any changes in miRNA levels are useful in predicting early onset preeclampsia (EOPE) and adverse perinatal outcomes. Methods: A total of 89 pregnant patients were enrolled in this prospective case-control study (55 PE and 34 healthy controls). miR-17, miR-20a, miR-20b, miR126, miR155, miR-200, miR-222, and miR-210 levels were studied in maternal serum in preeclamptic pregnant women. The Real-time RT-PCR method was used to determine maternal serum miRNA levels. Results: Serum miR-17, miR-20a, miR-20b, miR126, and miR-210 levels were significantly higher in PE than the control group . Increased miR-17, miR-20a, and miR-20b levels were independently associated with PE. Increased miR-17 and miR-126 levels were negatively correlated with serum EOPE in PE, and increased miR-210 levels were significantly positively correlated with EOPE in PE. Conclusion: Increased expression of serum miR-17, miR-20a, miR-20b, miR126, and miR-210 were found to be associated with PE, also increased expression of miR-17, miR-20a and miR-20b were to be prediction with PE, also increased maternal serum miR-17 and miR-126 expressions were negatively correlated and increased miR-210 expression was positively correlated with EOPE in PE women.
- 27 April 2023
- Published by Springer Nature in Research Square
Open AccessAre vascular endothelium and angiogenesis effective MicroRNA Biomarkers associated with the prediction of early-onset preeclampsia (EOPE) and adverse perinatal outcomes?
Purpose : We aimed to investigate serum MicroRNA (miRNA) levels in preeclampsia (PE) and to determine whether any changes in miRNA levels are useful in predicting early onset preeclampsia (EOPE) and adverse perinatal outcomes. Methods: A total of 89 pregnant patients were enrolled in this prospective case-control study (55 PE and 34 healthy controls). miR-17, miR-20a, miR-20b, miR126, miR155, miR-200, miR-222, and miR-210 levels were studied in maternal serum in preeclamptic pregnant women. The Real-time RT-PCR method was used to determine maternal serum miRNA levels. Results: Serum miR-17, miR-20a, miR-20b, miR126, and miR-210 levels were significantly higher in PE than the control group . Increased miR-17, miR-20a, and miR-20b levels were independently associated with PE. Increased miR-17 and miR-126 levels were negatively correlated with serum EOPE in PE, and increased miR-210 levels were significantly positively correlated with EOPE in PE. Conclusion: Increased expression of serum miR-17, miR-20a, miR-20b, miR126, and miR-210 were found to be associated with PE, also increased expression of miR-17, miR-20a and miR-20b were to be prediction with PE, also increased maternal serum miR-17 and miR-126 expressions were negatively correlated and increased miR-210 expression was positively correlated with EOPE in PE women.
- 24 June 2021
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (3) , 396-402
Are body roundness index and a body shape index in the first trimester related to foetal macrosomia?
This study investigated the effectiveness of maternal Body Roundness Index (BRI), Body Shape Index (ASBI), and Visceral Adiposity Index (VAI) in predicting foetal macrosomia and small for gestational age (SFGA) babies in obese and non-obese pregnant women. This prospective trial included 168 pregnant women (99 obese and 69 non-obese). A logistic regression model was used to identify the independent risk factors of foetal macrosomia and SFGA. BRI, waist/hip ratio, HbA1c and HOMA-IR were found to be significantly associated with increased macrosomia risk in obese women (OR = 1.469, % CI: 1.126–1.917, p = .005; OR = 4.289, % CI: 0.178–1.030, p = .012, OR = 6.277, %Cl: 1.233–31.948, p = .027, and OR = 1.393, %Cl: 1.060–1.832, p = .017). The present study indicates that first-trimester BRI and waist/hip ratio may be powerful determinants in predicting foetal macrosomia in obese pregnant women.
- 24 June 2021
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (3) , 396-402
Are body roundness index and a body shape index in the first trimester related to foetal macrosomia?
This study investigated the effectiveness of maternal Body Roundness Index (BRI), Body Shape Index (ASBI), and Visceral Adiposity Index (VAI) in predicting foetal macrosomia and small for gestational age (SFGA) babies in obese and non-obese pregnant women. This prospective trial included 168 pregnant women (99 obese and 69 non-obese). A logistic regression model was used to identify the independent risk factors of foetal macrosomia and SFGA. BRI, waist/hip ratio, HbA1c and HOMA-IR were found to be significantly associated with increased macrosomia risk in obese women (OR = 1.469, % CI: 1.126–1.917, p = .005; OR = 4.289, % CI: 0.178–1.030, p = .012, OR = 6.277, %Cl: 1.233–31.948, p = .027, and OR = 1.393, %Cl: 1.060–1.832, p = .017). The present study indicates that first-trimester BRI and waist/hip ratio may be powerful determinants in predicting foetal macrosomia in obese pregnant women.
- 21 January 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 5108-5116
The role of thyroid-stimulating hormone and thyroglobulin antibody in abnormally invasive placenta
Thyroid hormones and antibodies are known to participate in angiogenesis and invasion and also thyroid hormone receptors are expressed in the placenta. We aimed to evaluate the relationship of seru...
- 21 January 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 5108-5116
The role of thyroid-stimulating hormone and thyroglobulin antibody in abnormally invasive placenta
Thyroid hormones and antibodies are known to participate in angiogenesis and invasion and also thyroid hormone receptors are expressed in the placenta. We aimed to evaluate the relationship of seru...
- 30 December 2020
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 59 (4) , 320-323
Presentation of ultrasound and magnetic resonance imaging findings of omphalopagus conjoined twins in the intrauterine and postpartum period
Conjoined twins are extremely rare congenital malformations. Any associated genetic, environmental or demographic factors have not been identified. The phenomenon occurs between the 13th and 15th day after fertilization due to failure in splitting of embryonic axis. Twins are classified according to the major site of union, with the suffix pagus meaning fixed or fastened. Omphalopagus twins are the second most common variety of conjoined twins and usually are joined at the umbilicus. A 31-year-old pregnant female admitted for routine gestational control. Obstetric ultrasound (US) revealed two fetuses which were adherent from abdominal region. Their livers were fused however other organs were separated. Hepatic veins and portal veins were separated in both fetuses on color Doppler evaluation. Fetal magnetic resonance imaging (MRI) confirmed the diagnosis as omphalopagus conjoined twins. Twins were successfully delivered by cesarean section at 34th gestational week. Herein, US and MRI features of this rare anomaly in intrauterine and postpartum period are presented.
- 30 December 2020
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 59 (4) , 320-323
Presentation of ultrasound and magnetic resonance imaging findings of omphalopagus conjoined twins in the intrauterine and postpartum period
Conjoined twins are extremely rare congenital malformations. Any associated genetic, environmental or demographic factors have not been identified. The phenomenon occurs between the 13th and 15th day after fertilization due to failure in splitting of embryonic axis. Twins are classified according to the major site of union, with the suffix pagus meaning fixed or fastened. Omphalopagus twins are the second most common variety of conjoined twins and usually are joined at the umbilicus. A 31-year-old pregnant female admitted for routine gestational control. Obstetric ultrasound (US) revealed two fetuses which were adherent from abdominal region. Their livers were fused however other organs were separated. Hepatic veins and portal veins were separated in both fetuses on color Doppler evaluation. Fetal magnetic resonance imaging (MRI) confirmed the diagnosis as omphalopagus conjoined twins. Twins were successfully delivered by cesarean section at 34th gestational week. Herein, US and MRI features of this rare anomaly in intrauterine and postpartum period are presented.
- 24 November 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (6) , 904-909
Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels
Our aim was to investigate serum zonulin levels in intrahepatic cholestasis of pregnancy (ICP) and to determine the usefulness of zonulin in ICP follow-up. A prospective case-control study was carried out which included 88 pregnant women (44 patients with ICP and 44 controls). Maternal serum samples obtained from all participants and zonulin levels were determined by enzyme-linked immunosorbent assay (ELISA). Compared with controls, women with ICP had significantly higher zonulin levels (mean 0.728 ± 0.520 ng/mL vs. 1.303 ± 0.63 ng/mL, p <.001). According to the receiver operating characteristic (ROC) analysis performed for the predictive value of zonulin levels for ICP, the area under the curve (AUC) was 0.761 (95% CI: 0.661–0.860). Multivariable logistic regression analysis revealed serum zonulin levels was independently associated with adverse perinatal outcomes (OR = 1.278, 95% CI: 0.232–7.041), severity ICP (OR: 7.535, 95% CI: 1.597–13.553) and also unresponsiveness to treatment in ICP (OR: 4.178, 95% CI: 0.929–8.784).
- 24 November 2020
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 41 (6) , 904-909
Association of adverse outcomes of intrahepatic cholestasis of pregnancy with zonulin levels
Our aim was to investigate serum zonulin levels in intrahepatic cholestasis of pregnancy (ICP) and to determine the usefulness of zonulin in ICP follow-up. A prospective case-control study was carried out which included 88 pregnant women (44 patients with ICP and 44 controls). Maternal serum samples obtained from all participants and zonulin levels were determined by enzyme-linked immunosorbent assay (ELISA). Compared with controls, women with ICP had significantly higher zonulin levels (mean 0.728 ± 0.520 ng/mL vs. 1.303 ± 0.63 ng/mL, p <.001). According to the receiver operating characteristic (ROC) analysis performed for the predictive value of zonulin levels for ICP, the area under the curve (AUC) was 0.761 (95% CI: 0.661–0.860). Multivariable logistic regression analysis revealed serum zonulin levels was independently associated with adverse perinatal outcomes (OR = 1.278, 95% CI: 0.232–7.041), severity ICP (OR: 7.535, 95% CI: 1.597–13.553) and also unresponsiveness to treatment in ICP (OR: 4.178, 95% CI: 0.929–8.784).
- 1 June 2020
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 19 (3) , 271-276
Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis
- 1 June 2020
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 19 (3) , 271-276
Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis